Should bring our cash and cash equivalents up to $1M+ now as they reported
No risk of dilution this quarter as 'material transactions are in process that aren't reflected in the shareprice'
Around 3 quarters worth of capital and debt free - great place to be for a junior bio on the edge of becoming cash flow positive
Assuming Brazil and Taiwan both worth around $3M each, currently negotiating $6M worth of cashflow per year, with a cap of just $10M
Rerating opportunity ?
Should bring our cash and cash equivalents up to $1M+ now as...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)